Multiple Manufacturers

ISOVUE-300

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Multiple Manufacturers

Isovue-300 HCPCS:

Q9967

HCPCS Code Descriptor:

Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml

Category:

Q Code

Isovue-300 NDCs:

00019-1323-00, 00019-1332-00, 00270-1412-15, 00019-1333-90, 50419-0344-21, 00019-1333-21, 00019-1332-21, 00019-1323-90, 00019-1323-21, 00407-1414-90, 00019-1332-90, 00019-1323-85, 00270-1316-37, 50419-0346-15, 00019-1333-95, 70436-0126-82, 00270-1315-50, 00019-1332-16, 00019-1333-16, 00019-1323-95, 00019-1323-16, 50419-0344-15, 00270-1316-04, 65219-0383-05, 00407-2223-16, 00270-1316-35, 00407-1414-89, 50419-0344-12, 00270-1316-30, 50419-0346-10, 00019-1333-06, 00407-1413-61, 00019-1333-11, 00019-1332-06, 00019-1323-06, 00270-1315-35, 00019-1332-11, 00019-1333-52, 00019-1323-11, 00407-1413-59, 00019-1323-52, 00019-1333-78, 00019-1323-78, 00407-1413-10, 50419-0344-10, 00270-1316-52, 00270-1315-47, 50419-0346-05, 00019-1323-02, 50419-0344-05, 00407-2223-23, 00270-1315-25, 00270-1315-30, 00407-1414-72, 65219-0383-70, 00407-1413-72, 50419-0346-58, 00407-2223-21, 00270-1316-41, 50419-0344-58, 00407-1414-94, 65219-0383-50, 00270-1315-41, 00270-1316-95, 00407-2223-19, 00270-1315-95, 00407-1413-65, 50419-0346-25, 00270-1316-98, 00407-1414-93, 00270-1315-98, 00019-1333-27, 65219-0383-10, 00019-1323-27, 00407-2223-17, 00270-1316-45, 00019-1323-61, 00407-1414-91, 00019-1333-61, 00019-1332-61, 00019-1333-87, 00019-1323-87, 00270-1315-45, 00019-1333-00, 50419-0346-20, 00407-1413-63, 00407-1413-86, 00407-1414-82, 00407-2223-62, 00407-1413-62, 00407-1413-87, 00407-1414-84, 00407-2223-64, 00407-1413-53, 00407-1413-69, 00407-1414-76, 00407-1414-95, 00407-1413-88, 00407-1414-86, 00407-2223-66, 00407-1413-66, 00407-1414-87, 00407-2223-67, 00407-1413-68, 00407-1413-89, 00407-1414-88, 00407-1414-98, 00407-1413-48, 00407-1414-48

Primary Type:

Imaging/Radiopharmaceutical

Generic/Specialty Status:

Multi-Source

Package Type:

Not Found

Route of Administration:

Injection

Isovue-300 CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

00407-1413-63, 50419-0346-20, 00019-1333-00, 00270-1315-45, 00019-1333-87, 00019-1323-87, 00019-1332-61, 00407-1414-91, 00019-1333-61, 00019-1323-61, 00270-1316-45, 00019-1323-27, 00407-2223-17, 00019-1333-27, 65219-0383-10, 00270-1315-98, 00270-1316-98, 00270-1315-95, 00407-2223-19, 00270-1316-95, 65219-0383-50, 00270-1315-41, 50419-0344-58, 00407-1414-94, 00270-1316-41, 00407-1413-72, 50419-0346-58, 00407-2223-21, 65219-0383-70, 00270-1315-25, 00270-1315-30, 00407-1414-72, 00407-2223-23, 00019-1323-02, 50419-0344-05, 50419-0346-05, 00270-1316-52, 00270-1315-47, 50419-0344-10, 00019-1323-78, 00407-1413-10, 00019-1323-52, 00019-1333-78, 00407-1413-59, 00019-1333-52, 00019-1323-11, 00270-1315-35, 00019-1332-11, 00019-1323-06, 00019-1332-06, 00019-1333-11, 00407-1413-61, 00019-1333-06, 50419-0346-10, 00270-1316-30, 50419-0344-12, 00407-1414-89, 00270-1316-35, 00407-2223-16, 50419-0344-15, 00019-1323-16, 00019-1323-95, 00019-1333-16, 00019-1332-16, 00270-1315-50, 70436-0126-82, 00019-1333-95, 50419-0346-15, 00019-1323-85, 00019-1332-90, 00407-1414-90, 00019-1323-21, 00019-1323-90, 00019-1332-21, 00019-1333-21, 50419-0344-21, 00019-1333-90, 00270-1412-15, 00019-1332-00, 00019-1323-00, 00407-1414-93, 50419-0346-25, 65219-0383-05, 00270-1316-04, 00270-1316-37, 00407-1413-65

About Isovue-300:

ISOVUE-300 is a medication manufactured by multiple manufacturers and aligned to the Q Code: Q9967. ISOVUE-300 is administered via the injection route of administration.

Isovue-300 is a radiopaque contrast agent that is used in radiological examinations to help blood vessels, organs, and other non-bony tissues appear more visible. Isovue-300 contains iodine, a substance that absorbs x-rays. Isovue-300 is used to help diagnose heart, brain, blood vessel, and nervous system disorders.

ACCESS PRICING AND MORE BY REGISTERING

Q9967 Added Date:

January 1, 2008

Q9967 Effective Date:

January 1, 2008

Q9967 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Isovue-300 billing and coding information.
Our team did not identify a source for Isovue-300 patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for ISOVUE-300
Our team has not yet identified a source of side effects information for ISOVUE-300. Please check back in a few weeks.